Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cyp-001 (2 trials)
autologous mesenchymal stem cells (1 trial)
Acute Lung Injury (Phase 2)
Graft vs Host Disease (Phase 1)
Respiratory Distress Syndrome (Phase 2)
Respiratory Distress Syndrome, Newborn (Phase 2)
Trials (3 total)
Trial APIs (2 total)